Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals

…, ME Khamseh, F Alaei-Shahmiri, A Mehrtash… - Microbial …, 2017 - Elsevier
Recent studies indicate that inflammatory reactions leading to the development of type 2
diabetes mellitus (T2DM) may also contribute to variations in the composition of the intestinal …

MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene …

A Afgar, P Fard-Esfahani, A Mehrtash… - Cancer biology & …, 2016 - Taylor & Francis
It is observed that upregulation of DNMT3B enzyme in some cancers, including colon cancer,
could lead to silencing of tumor suppressor genes. MiR-339 and miR-766 have been …

[HTML][HTML] Detection of aberrant methylated SEPT9 and NTRK3 genes in sporadic colorectal cancer patients as a potential diagnostic biomarker

…, M Ghojazadeh, AH Mehrtash… - Oncology …, 2016 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most common malignancies, and the third leading
cause of cancer mortality worldwide. Timely detection of CRC in patients with earlier stages …

Low expression of isocitrate dehydrogenase 1 (IDH1) R132H is associated with advanced pathological features in laryngeal squamous cell carcinoma

…, M Mohammadpour, E Jafari, A Mehrtash… - Journal of Cancer …, 2023 - Springer
Introduction Recent developments in genomic sequencing have led to the identification of
somatic mutations in isocitrate dehydrogenase 1 (IDH1) in various malignancies. IDH1 R132H …

RAB7L1 promoter polymorphism and risk of Parkinson's disease; a case-control study

…, M Goudarzian, A Moslem, A Mehrtash… - Neurological …, 2017 - Taylor & Francis
Introduction: Recent genome-wide association studies have explored some new loci in
association with Parkinson’s disease (PD). RAB7L1 is an important gene involved in one of the …

Hypomethylation of NANOG promoter in colonic mucosal cells of obese patients: a possible role of NF-κB

…, K Pourvali, L Teimoori-Toolabi, A Mehrtash… - British journal of …, 2019 - cambridge.org
Obesity and particularly central obesity are the main risk factors of colon cancer. All intestinal
cell populations including stem cells, their progenitors and differentiated colonocytes seem …

TCF4 silencing sensitizes the colon cancer cell line to oxaliplatin as a common chemotherapeutic drug

…, L Teimoori-Toolabi, A Mehrtash… - Anti-cancer …, 2014 - journals.lww.com
Colon cancer is among the most prevalent cancers worldwide. Although the main modality
of treatment is surgery, resistance to chemoradiotherapy raises concerns. Hence, we aimed …

Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan

…, M Ghanbarian, H Kalhor, A Mehrtash… - Cancer Chemotherapy …, 2020 - Springer
Drug resistance to irinotecan and oxaliplatin, two widely used chemotherapeutic, has become
a common problem in cancerous patients. Despite numerous valuable studies, distinct …

Towards solving the genetic diagnosis odyssey in Iranian patients with congenital anomalies

…, M Malekian, M Mokhberdezfuli, A Mehrtash… - European Journal of …, 2024 - nature.com
Understanding the underlying causes of congenital anomalies (CAs) can be a complex
diagnostic journey. We aimed to assess the efficiency of exome sequencing (ES) and …

Among autophagy genes, ATG16L1 but not IRGM is associated with Crohn's disease in Iranians

L Teimoori-Toolabi, S Samadpoor, A Mehrtash… - Gene, 2018 - Elsevier
Background The prevalence of inflammatory bowel diseases is uprising in countries like Iran.
Genetic predisposing elements play prominent role in the pathogenesis of Crohn's disease…